F. Nicoletti et al., ENDOTOXIN-INDUCED LETHALITY IN NEONATAL MICE IS COUNTERACTED BY INTERLEUKIN-10 (IL-10) AND EXACERBATED BY ANTI-IL-10, Clinical and diagnostic laboratory immunology, 4(5), 1997, pp. 607-610
The lethal effects occurring in neonatal (<24-h-old) BALB/c mice after
challenge with 25 mg of lipopolysaccharide (LPS) per kg of body weigh
t were significantly counteracted by pretreatment with recombinant int
erleukin-10 (rIL-10; 25 or 50 ng/mouse). Concordantly, blockage of end
ogenous IL-10 with the SXC1 monoclonal antibody increased LPS-induced
mortality. Both IL-10 and SXC1 modulated the release of tumor necrosis
factor alpha (TNF-alpha) so that, relative to controls, peak TNF-alph
a values after LPS challenge were decreased by rIL-10 and increased by
anti-IL-10.